Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes.
Matt Martin, PharmD, BCSCP
Advertisement
Matt Martin, PharmD, BCSCP, vice president of clinical services at PCCA
Articles by Matt Martin, PharmD, BCSCP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Brytly for OTC Eye Redness Relief
2
Pharmacists Must Guide Peptide Talks Pending FDA Action | NCPA 2026
3
Q&A: Emerging Compounded Therapies Demand Pharmacist’s Clinical Judgment | NCPA 2026
4
American Pharmacists Month: Celebrating the Pharmacist’s Community Role
5